Tabid, Cyruz .
HRN: 22-63-05 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2025
CEFUROXIME 750MG (VIAL)
01/10/2025
01/17/2025
INTRAVENOUS
330 Mg
Every 8 Hours
PCAP-C
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes